LAVA Therapeutics N.V. (LVTX) Tops Q2 EPS by 2c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q2 EPS of ($0.31), $0.02 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• IP Strategy Holdings receives Nasdaq noncompliance notice over late 10-Q
• Gamma Resources raises private placement ceiling to $1.75M